Clemencia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 10.00 K
as on 13-12-2024
- Company Age 5 Year, 20 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.00 M
as on 13-12-2024
- Revenue -53.43%
(FY 2022)
- Profit -79.65%
(FY 2022)
- Ebitda -253.96%
(FY 2022)
- Net Worth 4.50%
(FY 2022)
- Total Assets 29.73%
(FY 2022)
About Clemencia Life Sciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 10.00 K .
The company currently has active open charges totaling ₹1.00 M.
Sujeet Srivastava, Mohini Srivastava, and Siddhesh Mohan serve as directors at the Company.
- CIN/LLPIN
U24290MH2020PTC335645
- Company No.
335645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2020
- Date of AGM
27 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Clemencia Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujeet Srivastava  | Director | 07-Jan-2020 | Current |
| Mohini Srivastava | Director | 07-Jan-2020 | Current |
| Siddhesh Mohan | Director | 11-May-2020 | Current |
Financial Performance of Clemencia Life Sciences.
Clemencia Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 53.43% decrease. The company also saw a substantial fall in profitability, with a 79.65% decrease in profit. The company's net worth moved up by a moderate rise of 4.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clemencia Life Sciences?
Unlock access to Clemencia Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cradle Educations Private LimitedActive 16 years 10 monthsSujeet Srivastava and Mohini Srivastava are mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2020 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Clemencia Life Sciences?
Unlock and access historical data on people associated with Clemencia Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clemencia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clemencia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.